Indications
Zelnorm is indicated for the repeated symptomatic short-term treatment of women with Irritable Bowel Syndrome (IBS) whose predominant bowel habit is constipation, associated with abdominal pain/discomfort or bloating (see section 4.2).
Composition
- Active substance
- tegaserod
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zelnorm
- Active substance
- tegaserod
- ATC code
- A03AE02
- Therapeutic area
- Irritable Bowel Syndrome
- Marketing authorisation holder
- Novartis Europharm Limited
- Status
- Refused